Cart
sales@molnova.com
NSC-34931
CAS No. 6962-42-1
NSC-34931( NSC34931 | Stilbenavir )
Catalog No. M15665 CAS No. 6962-42-1
A anti-HIV-1 compound that interferes with HIV-I integrase binding to viral DNA.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC-34931
-
NoteResearch use only, not for human use.
-
Brief DescriptionA anti-HIV-1 compound that interferes with HIV-I integrase binding to viral DNA.
-
DescriptionA anti-HIV-1 compound that interferes with HIV-I integrase binding to viral DNA.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC34931 | Stilbenavir
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6962-42-1
-
Formula Weight928.747
-
Molecular FormulaC34H20N4Na4O14S4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1=CC=C2C(=C1)C(=CC(=C2O)N=NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+]
-
Chemical Name(3Z)-4-oxo-3-[[4-[(E)-2-[4-[(2Z)-2-(1-oxo-4-sulfonatonaphthalen-2-ylidene)hydrazinyl]-2-sulfonatophenyl]ethenyl]-3-sulfonatophenyl]hydrazinylidene]naphthalene-1-sulfonate tetrasodium
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang W, et al. Leukemia. 2016 Jul;30(7):1502-9.
2. Patent WO2008042806A2.
molnova catalog
related products
-
IMB-301
IMB-301 (NSC 301209) is a small molecule inhibitor that target the binding interface of the HIV-1 Vif/hA3G complex.
-
Navuridine
Navuridine is an oral active inhibitor of HIV reverse transcriptase with a relatively short half-life.
-
HIV p17 Gag 77-85
HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.
